Viewing nowCombinationTelmisartan and Amlodipine Dual Tablet 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Lightpharmtech Co., Ltd.

MFDS item code 201903426 · Approved 2019.05.27 · Insurance code 690301180
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Amlodipine or Telmisartan alone. This drug effectively lowers blood pressure and helps reduce the risk of cardiovascular diseases. In cases where blood pressure control is difficult, it can contribute to stabilizing blood pressure through combination therapy. Therefore, it provides an appropriate treatment option for patients struggling with blood pressure management.
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medication may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be administered this medication with caution’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.
The safety and efficacy of this medication have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. This drug should not be administered to individuals who are allergic to its ingredients or similar medications, have biliary obstruction, severe liver disease, aortic stenosis due to heart problems, severe hypotension, are in shock, have unstable heart failure after acute myocardial infarction, have certain genetic conditions, or have diabetes or severe kidney impairment. This medication should be used with caution in patients with primary aldosteronism or certain heart valve disorders, liver dysfunction, gastrointestinal diseases, renovascular hypertension, dialysis patients, and the elderly, and caution is also required when used in combination with other antihypertensive medications. Taking this drug may result in various side effects, including dizziness, peripheral edema, palpitations, hypotension, dyspepsia, and rashes. If any unusual symptoms occur, medical consultation should be sought immediately. It is important not to take this medication during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately, and alternative treatment should be sought. Nursing mothers are also advised not to take this medication. Patients with impaired kidney function should have their blood potassium and kidney function tested regularly while taking this medication, and caution should be exercised in patients with hypotension or heart failure. This medication may interact with other drugs, so if you are taking other medications, it is essential to inform your healthcare provider, especially when taken with lithium, digoxin, warfarin, nonsteroidal anti-inflammatory drugs, simvastatin, grapefruit juice, etc. This drug is not recommended for children as its safety and efficacy have not been adequately established, and for the elderly, it is advisable to start with a low dose and gradually increase the dosage. In case of overdose, there is a risk of hypotension, dizziness, and acute renal failure, so immediate medical attention should be sought for appropriate treatment. This medication should be kept out of reach of children, and it is recommended to open the packaging just before use.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a container that blocks light. Moreover, it is best stored at room temperature between 1 and 30 degrees Celsius. Proper storage will ensure the safe maintenance of the medication's efficacy.
White and light gray, biconvex oval dual tablets
30 tablets/box [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Lightpharmtech Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.